Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / August 17, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Principia Biopharma Inc. (NASDAQ:PRNB) to Sanofi for $100 per share in cash is fair to Principia shareholders. On behalf of Principia shareholders, Halper S...
Merger activity increased significantly last week with eight new deals announced and one deal terminated. This is the highest number of deals announced in a single week this year but most of these deals were relatively small compared to the multi-billion-dollar deals we saw in the week prior...
PARIS and SOUTH SAN FRANCISCO, Calif. , Aug. 17, 2020 /PRNewswire/ -- Sanofi and Principia Biopharma Inc. (NASDAQ: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, entered into a definitive agreement under which Sanofi will acq...
Principia Biopharma (NASDAQ: PRNB ) : Q2 GAAP EPS of $0.31 beats by $1.36 . More news on: Principia Biopharma Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune mediated diseases, today announced financial results for the second quarter ended June 30, 2020. ...
Chatter about a potential buyout has lifted the stock of immune-disorder therapy developer Principia Biopharma (NASDAQ: PRNB ) - shares are up 13.6% since Sanofi (NASDAQ: SNY ) was linked to interest, and they're up 49% over the past three weeks - but a takeover isn't even part of ...
Biotech Pulse Biotechs continue to be one of the leading healthcare groups and along with diagnostics represent two of the best segments of healthcare. The first half saw biotechs recover quicker from the March selloff than most of the market, and reach a milestone that took 5 years to achie...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Principia Biopharma Perks Up on Sanofi Rumors Principia Biopharma (PRNB) shot up due to swirling rumors regarding Sanofi's (SNY) interest in the firm. The French pharma company is currently looking to expand its presence in the United States and is weighing different options. Principia is ...
Gainers: InnerWorkings (NASDAQ: INWK ) +117% . More news on: InnerWorkings, Inc., Heat Biologics, Inc., Boxlight Corporation, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Principia Biopharma Inc. Company Name:
PRNB Stock Symbol:
NASDAQ Market:
Principia Biopharma Inc. Website:
SOUTH SAN FRANCISCO, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc., a Sanofi company, focused on developing treatments for immune mediated diseases, today announced it has completed patient enrollment into the global Phase 3 PEGASUS trial for rilzabrutinib, an oral inve...
NEW YORK, NY / ACCESSWIRE / September 19, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Maxim Integrated Products, Inc. (NASDAQ: MXIM...
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune mediated diseases, today announced that the first patient was dosed in an open label two-arm trial to e...